We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

68 hedge funds and large institutions have $404M invested in Oxford Immunotec Global PLC Ordinary Shares in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

2% less capital invested

Capital invested by funds: $411M → $404M (-$6.75M)

7% less funds holding

Funds holding: 73 → 68 (-5)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

Holders
68
Holders Change
-5
Holders Change %
-6.85%
% of All Funds
1.34%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
11
Increased
26
Reduced
24
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Penn Capital Management
Pennsylvania
+$6.19M
2
FLAM
First Light Asset Management
Minnesota
+$5.87M
3
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$4.65M
4
ECM
Endurant Capital Management
California
+$3.71M
5
FA
Friess Associates
Delaware
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$9.95M
2
Invesco
Invesco
Georgia
-$9.6M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$8.14M
4
Man Group
Man Group
United Kingdom
-$6.06M
5
FI
Fosun International
China
-$2.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$2.25M +$103K +6,376 +5%
Neuberger Berman Group
27
Neuberger Berman Group
New York
$2.24M -$133K -8,200 -6%
KOCAA
28
Knights of Columbus Asset Advisors
Connecticut
$2.14M +$2.09M +128,921 New
Two Sigma Investments
29
Two Sigma Investments
New York
$2.06M -$21.1K -1,300 -1%
Connor, Clark & Lunn Investment Management (CC&L)
30
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.98M -$19.5K -1,200 -1%
ZIM
31
Zacks Investment Management
Illinois
$1.94M +$359K +22,157 +23%
JP Morgan Chase
32
JP Morgan Chase
New York
$1.92M +$10.6K +656 +0.6%
Morgan Stanley
33
Morgan Stanley
New York
$1.74M -$1.96M -120,949 -54%
OAM
34
Oxford Asset Management
United Kingdom
$1.65M -$525K -32,360 -25%
Squarepoint
35
Squarepoint
New York
$1.36M +$464K +28,586 +54%
KCM
36
Kornitzer Capital Management
Kansas
$1.34M – – –
OC
37
Oppenheimer & Co
New York
$1.17M -$114K -7,000 -9%
WG
38
Winton Group
United Kingdom
$1.16M -$78.4K -4,837 -6%
Wells Fargo
39
Wells Fargo
California
$1.11M +$427K +26,305 +65%
AllianceBernstein
40
AllianceBernstein
Tennessee
$1.1M +$1.08M +66,500 New
OAM
41
Oberweis Asset Management
Illinois
$1.08M +$102K +6,300 +11%
QI
42
QS Investors
New York
$943K -$30.8K -1,900 -3%
HWM
43
HighMark Wealth Management
Minnesota
$830K +$811K +50,037 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$824K +$598K +36,900 +290%
Northern Trust
45
Northern Trust
Illinois
$754K -$890K -54,876 -55%
CCIA
46
Campbell & Co Investment Adviser
Maryland
$595K +$193K +11,893 +50%
State Street
47
State Street
Massachusetts
$579K +$37.6K +2,320 +7%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$578K +$213K +13,159 +61%
WCM
49
Weld Capital Management
New York
$566K +$552K +34,074 New
Geode Capital Management
50
Geode Capital Management
Massachusetts
$313K – – –
1
2
3 4

OXFD Hedge Fund Activity: Q4 2019 in Review

68 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2019, worth a combined $404M — down 1.6% from $411M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of OXFD and 11 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 26 added.

The largest buyer was Penn Capital Management, adding an estimated $6.19M. The largest seller was Millennium Management, cutting an estimated $9.95M.

  • 68 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2019, down from 73 in Q3 2019.
  • Funds reported $404M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2019, down 1.6% quarter-over-quarter.
  • 11 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2019 and 15 closed out, a net change of -4 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2019 was Penn Capital Management, an estimated $6.19M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2019 was Millennium Management, an estimated $9.95M sold.

Based on aggregated 13F filings for Q4 2019.